Natus Medical, Inc. (NASDAQ:BABY)

Hidden Gem

yes

I think this is pretty much fairly valued at 16.50, but I think it could run to 25 or higher depending on growth projections/realized growth.

Good management, expanding in the neonatalogy arena, making strategic accretive acquisitions

Five star stock near 52 week low.

is the largest, continues to expand and is in good position to increase its testing and add new products

There will always be babies somewhere.

Great potential for long-term growth, especially as they successfully integrate their most recent acquisition. Lots of cash on hand, too.

Before this BABY gets thrown out with the bathwater I am going to purchase a few shares. I like the space where BABY operates and believe that the market is there for their products. Just need a little more economic wind behind them.

BABY is executing on a strategy of growth by acquisition. I like to think of them as the next Cytyc.

small cap company with potential.

This account tracks the fast-growing shakers and movers and some of the riskier stocks on my watch list.

hidden gem, 5-star, healthcare technology

Solid track record of acquisition integration, expansion into European market.

Many smart fools

baby heatlh care products, good company

RL purchased at 7.75

technological edge

Natus Medical Incorporated/ AKA (BABY) is a provider of healthcare products for the monitoring, screening,detection,treatment,and tracking of (common) medical ailments in the you better care for my newborn's industry. Everything from hearing impairments,neurological dysfunctions,from epilepsy,sleep disorders to balance and mobility disorders. To date products include computerized neurodiagnostic systems for audiology,neurology,polysomnography,and neonatology,as well as care products and phototherapy devices for treatment of newborn jaundice,head cooling products for the treatment of brain injury in newborns and software systems for tracking and managing diseases and disorders for public health laboratories.After having two full grown son's behind me,this company looks like a long term winner to keep mother and father happy with the medical care of their newborn and should be considered under $10. $230 market cap PE around 13.00 REO around 11.00 Net profit around 12% and a sum of free cash on hand with low dept. One to watch for sure.